Jurgen Podlech

Jurgen Podlech

Mainz, RP, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient.

Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient.

Journal: NPJ genomic medicine
Published: August 03, 2024

Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells.

Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells.

Journal: PLoS pathogens
Published: August 30, 2023

Memory CD8 T Cells Protect against Cytomegalovirus Disease by Formation of Nodular Inflammatory Foci Preventing Intra-Tissue Virus Spread.

Memory CD8 T Cells Protect against Cytomegalovirus Disease by Formation of Nodular Inflammatory Foci Preventing Intra-Tissue Virus Spread.

Journal: Viruses
Published: April 13, 2022

Host-Adapted Gene Families Involved in Murine Cytomegalovirus Immune Evasion.

Host-Adapted Gene Families Involved in Murine Cytomegalovirus Immune Evasion.

Journal: Viruses
Published: December 17, 2021

Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.

Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.

Journal: Frontiers in immunology
Published: April 13, 2021

Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission.

Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission.

Journal: Medical microbiology and immunology
Published: March 11, 2021

Life-threatening disseminated enterovirus infection during combined rituximab and ibrutinib maintenance treatment for mantle cell lymphoma: a case report.

Life-threatening disseminated enterovirus infection during combined rituximab and ibrutinib maintenance treatment for mantle cell lymphoma: a case report.

Journal: Journal of medical case reports
Published: May 21, 2020

Positive Role of the MHC Class-I Antigen Presentation Regulator m04/gp34 of Murine Cytomegalovirus in Antiviral Protection by CD8 T Cells.

Positive Role of the MHC Class-I Antigen Presentation Regulator m04/gp34 of Murine Cytomegalovirus in Antiviral Protection by CD8 T Cells.

Journal: Frontiers in cellular and infection microbiology
Published: April 24, 2020

Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation.

Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation.

Journal: Frontiers in cellular and infection microbiology
Published: March 11, 2020

Cytomegalovirus-Associated Inhibition of Hematopoiesis Is Preventable by Cytoimmunotherapy With Antiviral CD8 T Cells.

Cytomegalovirus-Associated Inhibition of Hematopoiesis Is Preventable by Cytoimmunotherapy With Antiviral CD8 T Cells.

Journal: Frontiers in cellular and infection microbiology
Published: February 03, 2020

Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.

Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.

Journal: Frontiers in cellular and infection microbiology
Published: January 17, 2020

Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades' résumé.

Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades' résumé.

Journal: Medical microbiology and immunology
Published: February 26, 2019
Showing 1-12 of 28

Last Updated: 09/26/2026